Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
Cells of the pulmonary vasculature show a hyperproliferative phenotype in pulmonary arterial hypertension (PAH), thus contributing to the disease pathogenesis. Here the authors show that cyclin-dependent kinases are overactivated in PAH, and that their pharmacological inhibition attenuates the disea...
Guardado en:
Autores principales: | Astrid Weiss, Moritz Christian Neubauer, Dinesh Yerabolu, Baktybek Kojonazarov, Beate Christiane Schlueter, Lavinia Neubert, Danny Jonigk, Nelli Baal, Clemens Ruppert, Peter Dorfmuller, Soni Savai Pullamsetti, Norbert Weissmann, Hossein-Ardeschir Ghofrani, Friedrich Grimminger, Werner Seeger, Ralph Theo Schermuly |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4090a81f202846ada6a47e71478ee836 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling.
por: Xia Tian, et al.
Publicado: (2011) -
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
por: Swati Dabral, et al.
Publicado: (2019) -
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
por: Tatyana Novoyatleva, et al.
Publicado: (2021) -
Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer
por: Steffen Kiehl, et al.
Publicado: (2017) -
CyclinPred: a SVM-based method for predicting cyclin protein sequences.
por: Mridul K Kalita, et al.
Publicado: (2008)